# DOCE Study Interaction Between Direct Oral Anticoagulants and Drug-metabolizing Enzyme Inducers

> **NCT05750680** · — · ACTIVE_NOT_RECRUITING · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 23 (estimated)

## Conditions studied

- Atrial Fibrillation
- Thromboembolism, Venous

## Interventions

- **DRUG:** DOACs

## Key facts

- **NCT ID:** NCT05750680
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-05-13
- **Primary completion:** 2023-04-01
- **Final completion:** 2025-05-01
- **Target enrollment:** 23 (ESTIMATED)
- **Last updated:** 2025-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05750680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05750680, "DOCE Study Interaction Between Direct Oral Anticoagulants and Drug-metabolizing Enzyme Inducers". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT05750680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*